To: Department of Defense (DoD) / Defense Advanced Research Projects Agency (DARPA) / Department of Health and Human Services (HHS) / National Institutes of Health (NIH) / Centers for Disease Control and Prevention (CDC)

Request:

Requesting any and all research proposals, internal communications, contracts, memoranda, or reports from 2000 to present referencing the intentional or incidental use of infectious, microbial, or environmental agents to induce or exacerbate connective tissue degradation, fragility, or hypermobility, including:
	•	Studies evaluating pathogen-derived enzymes (e.g., collagenases, elastases) or chronic infection states in relation to connective tissue strength, wound healing, or musculoskeletal stability
	•	Research into microbial, viral, or fungal agents that alter extracellular matrix regulation, collagen crosslinking, or vascular integrity
	•	Modeling of population-level outcomes related to environmentally or pathogen-induced connective tissue weakening, including risk stratification or predictive analytics for medical, occupational, or behavioral domains
	•	Interagency or contractor communications regarding connective tissue compromise as a measurable factor in long-term behavioral monitoring, forecasting, or intervention design
	•	Reports linking connective tissue degradation to altered compliance, resilience, or vulnerability profiles in experimental or population health contexts

Keywords: connective tissue degradation, hypermobility, extracellular matrix, collagenase, elastase, pathogen-induced fragility, predictive analytics, behavioral modeling, resilience, risk stratification


///////////


To: Department of Defense (DoD) / Defense Advanced Research Projects Agency (DARPA) / Department of Health and Human Services (HHS) / National Institutes of Health (NIH) / Centers for Disease Control and Prevention (CDC)

Request:

Requesting any and all research proposals, internal communications, contracts, memoranda, or reports from 2000 to present referencing the deliberate or incidental use of infectious, microbial, or environmental agents to induce connective tissue degradation or hypermobility syndromes, including:
	•	Research into pathogen-derived mechanisms (e.g., collagenases, elastases, viral interference with extracellular matrix) as tools for producing long-term alterations in tissue strength or proprioception
	•	Studies examining induced hypermobility, fragility, or Ehlers–Danlos–like conditions as a means of creating persistent physiological baselines in test populations
	•	Analyses linking connective tissue weakening to altered compliance, decision-making, or vulnerability patterns in individuals and groups
	•	Population-level modeling projects where infection-induced fragility is used as a proxy for forecasting long-term resilience, adaptability, or susceptibility to external influence
	•	Interagency or contractor communications discussing connective tissue degradation as a lever in behavioral prediction markets, including any reference to “captive research cohorts” or “persistent subject designation”

Keywords: Ehlers–Danlos, hypermobility, connective tissue disorder, pathogen-induced fragility, extracellular matrix, collagenase, elastase, behavioral prediction, captive cohort, futures markets, resilience modeling


//////////


To: Department of Defense (DoD) / Defense Advanced Research Projects Agency (DARPA) / Department of Health and Human Services (HHS) / National Institutes of Health (NIH) / Centers for Disease Control and Prevention (CDC)

Request:

Requesting any and all research proposals, internal communications, contracts, memoranda, or reports from 2000 to present referencing Ehlers–Danlos Syndrome (EDS) or related connective tissue disorders in the context of:
	•	Military, aerospace, or high-performance physical applications, including injury modeling, joint stability under extreme conditions, and unique proprioceptive profiles in EDS cohorts
	•	Performance prediction algorithms or training adaptations for individuals with hypermobility or connective tissue fragility
	•	DARPA or DoD-funded studies into connective tissue vulnerability or resilience under environmental stressors (e.g., extreme temperature, microgravity, high G-force)
	•	Research into environmental triggers or exacerbators of EDS symptoms, including chemical exposures, airborne particulates, mold, or electromagnetic/radiation environments
	•	Cross-analysis of EDS with mast cell activation syndrome (MCAS) or dysautonomia in environmental exposure contexts
	•	Interagency or contractor communications on predictive modeling or risk stratification of EDS patients in occupational or deployment settings

Keywords: Ehlers–Danlos Syndrome, hypermobility, connective tissue disorder, performance prediction, injury modeling, DARPA, DoD, environmental exposure, mast cell activation syndrome, dysautonomia, microgravity, proprioception

//////////////

To: Department of Defense (DoD) / Defense Advanced Research Projects Agency (DARPA) / Department of Health and Human Services (HHS) / National Institutes of Health (NIH) / Centers for Disease Control and Prevention (CDC)

Request:

Requesting any and all research proposals, contracts, internal communications, or reports from 2000 to present referencing Ehlers–Danlos Syndrome (EDS) or related connective tissue disorders in the context of:
	•	Predictive modeling of physical performance, injury risk, or task suitability for individuals with EDS or hypermobility spectrum disorders
	•	Integration of EDS-specific variables into biometric, physiologic, or neurocognitive monitoring systems for forecasting individual capabilities or limitations
	•	Cross-referencing of genetic, biometric, or environmental exposure data to identify behavioral or performance patterns unique to EDS populations
	•	Application of EDS-related datasets in workforce optimization, mission role assignment, or occupational health surveillance programs
	•	Contractor or interagency collaboration on algorithmic profiling of EDS patients for risk assessment or operational deployment purposes

Keywords: Ehlers–Danlos Syndrome, hypermobility, connective tissue disorder, predictive modeling, biometric monitoring, occupational profiling, performance forecasting, injury risk, DARPA, DoD, behavioral profiling, workforce optimization

///////////

To: Department of Defense (DoD) / Defense Advanced Research Projects Agency (DARPA) / National Aeronautics and Space Administration (NASA) / National Institutes of Health (NIH) / Centers for Disease Control and Prevention (CDC)

Request:

Requesting any and all research proposals, contracts, internal communications, reports, or contractor deliverables from 1990 to present referencing Ehlers–Danlos Syndrome (EDS), Postural Orthostatic Tachycardia Syndrome (POTS), or related connective tissue and autonomic disorders in the context of:
	•	Simulated, altered, or variable gravity environments conducted on Earth (“terrestrial microgravity” or “artificial gravity” conditions)
	•	Studies involving the physiological or behavioral impact of small changes in gravitational load, acceleration, or gravitational gradient
	•	Medical or occupational health evaluations of individuals with EDS or POTS in centrifuge, parabolic flight, or gravity-simulation environments
	•	Research into circulatory, musculoskeletal, or neurological responses to gravitational variation in hypermobile or dysautonomia-affected populations
	•	Interagency or contractor collaborations on environmental exposure testing where gravitational conditions are a controlled or independent variable
	•	Any use of gravitational field manipulation technology for human performance modeling, risk assessment, or environmental safety evaluation

Keywords: Ehlers–Danlos Syndrome, hypermobility, Postural Orthostatic Tachycardia Syndrome, POTS, connective tissue disorder, dysautonomia, gravitational gradient, artificial gravity, terrestrial microgravity, gravity simulation, variable gravity, environmental exposure, DARPA, NASA, DoD


//////////


To: Department of Defense (DoD) / Defense Advanced Research Projects Agency (DARPA) / National Aeronautics and Space Administration (NASA) / U.S. Navy (NAVSEA / Office of Naval Research) / U.S. Air Force Research Laboratory (AFRL) / National Institutes of Health (NIH) / Centers for Disease Control and Prevention (CDC)

Request:

Requesting any and all research proposals, contracts, internal communications, reports, or contractor deliverables from 1990 to present referencing Ehlers–Danlos Syndrome (EDS), Postural Orthostatic Tachycardia Syndrome (POTS), or related connective tissue and autonomic disorders in the context of:
	•	Simulated, altered, or variable gravity environments conducted on Earth (“terrestrial microgravity” or “artificial gravity” conditions)
	•	Studies involving the physiological or behavioral impact of small changes in gravitational load, acceleration, or gravitational gradient, including induced gradients aboard naval or aerospace platforms
	•	Medical or occupational health evaluations of individuals with EDS or POTS in centrifuge, parabolic flight, or field-generated variable-gravity environments
	•	Research into circulatory, musculoskeletal, or neurological responses to gravitational variation in hypermobile or dysautonomia-affected populations
	•	Interagency or contractor collaborations on environmental exposure testing where gravitational conditions are a controlled or independent variable
	•	Contractor or subcontractor work related to “field-effect” physiology, gravity-gradient health impact assessments, or variable gravity control for human factors research

Please include responsive materials from or referencing the following facilities, programs, or contractors, where applicable:
	•	NASA Glenn Research Center – Variable Gravity Research Facility
	•	DARPA Biological Systems Under Variable Acceleration studies
	•	NAVSEA / ONR gravity gradient crew performance experiments
	•	AFRL Human Performance Wing – centrifuge and field-effect trials
	•	US Army Natick Labs environmental control research
	•	Contractors including BAE Systems Advanced Technologies, SAIC, Honeywell Aerospace, and any subcontractors working on gravity-simulation or gravitational field-effect apparatus with biomedical applications

Keywords: Ehlers–Danlos Syndrome, POTS, hypermobility, connective tissue disorder, dysautonomia, gravitational gradient, artificial gravity, terrestrial microgravity, variable gravity, environmental exposure, field-effect physiology, acceleration environment, human performance, DARPA, NASA, DoD, AFRL, NAVSEA, ONR


///////////


To: FOIA Officer, NASA Glenn Research Center

Request:

Requesting any and all research proposals, internal communications, contracts, or reports from 1990 to present referencing Ehlers–Danlos Syndrome (EDS), Postural Orthostatic Tachycardia Syndrome (POTS), or related connective tissue and autonomic disorders in studies involving simulated or variable gravity environments at the NASA Glenn Variable Gravity Research Facility or related test platforms.

This includes:
	•	Medical, biomechanical, or neurological evaluations of individuals with EDS or POTS under terrestrial microgravity, artificial gravity, or gravitational gradient conditions
	•	Collaborative projects with the Department of Defense, DARPA, AFRL, NAVSEA/ONR, or contractors such as BAE Systems Advanced Technologies, SAIC, or Honeywell Aerospace involving gravity simulation or gravitational field-effect apparatus with biomedical applications

Keywords: Ehlers–Danlos Syndrome, POTS, hypermobility, connective tissue disorder, dysautonomia, gravitational gradient, artificial gravity, terrestrial microgravity, variable gravity, environmental exposure, field-effect physiology, acceleration environment, NASA Glenn, Variable Gravity Research Facility


//////////


